You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NGNE Sale Disclosure
Cvijic Christine Mikail · SEC Form 4 · Filed Jul 7, 2026
Sale
Calculated transaction value
$151.76K
Cvijic Christine Mikail President And CFO
NGNE
Neurogene
NGNE
Transaction date
Jul 7, 2026
Public filing date
Jul 7, 2026
Filing lag
Filed same day
NGNE daily price context
Close on/before transaction
$36.8
Jul 7, 2026
First close after public filing
$38.24
Jul 8, 2026
30-day return after filing
-6.9%
Through Aug 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,200 shares @ $36.13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001543663-26-000017
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$173.38K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurogene Inc. NGNE Current | Sale | Jul 7, 2026 | $151.76K |
| Neurogene Inc. NGNE | Sale | Jul 6, 2026 | $21.61K |